TITLE:
Study of Remodulin in Patients With Critical Limb Ischemia With No Planned Revascularization Procedures

CONDITION:
Critical Limb Ischemia

INTERVENTION:
Remodulin (treprostinil sodium) Injection

SUMMARY:

      The purpose of this study is to assess and compare the safety of continuous and daily
      subcutaneous Remodulin therapy in patients with critical limb ischemia (CLI) with no planned
      vascular interventional procedures; and to determine the effect of Remodulin on wound
      healing and treadmill walk distance.
    

DETAILED DESCRIPTION:
NONE

ELIGIBILITY:
Gender: All
Age: 18 Years to 85 Years
Criteria:

        Patients with Stage III or IV critical limb ischemia due to documented peripheral arterial
        disease with no planned interventional vascular procedures
      
